Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Cited by (866)

Items 301–400 of 866

1. Adhesion Molecules in Multiple Myeloma Oncogenesis and Targeted Therapy
   Maroun Bou Zerdan, Lewis Fady Nasr, Joseph T. Kassab, Ludovic Saba, Myriam Ghossein, Marita Yaghi, Barbara Geraldine Dominguez, Chakra P. Chaulagain · 2022 · International Journal of Hematologic Oncology
2. Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives
   Wael M.Y. Mohamed, Jaya Kumar, Badrah Saeed Ali Alghamdi, Al-Hassan Soliman Wadan, Toshihide Yamashita · 2022 · IBRO Neuroscience Reports
3. Tissue-specific regulation of sirtuin and nicotinamide adenine dinucleotide biosynthetic pathways identified in C57Bl/6 mice in response to high-fat feeding
   Janice E. Drew, Andrew J. Farquharson, Graham William Horgan, Lynda M. Williams · 2016 · The Journal of Nutritional Biochemistry
4. Novel Immunotherapies for Multiple Myeloma
   Mattia D’Agostino, Mario Boccadoro, Eric L. Smith · 2017 · Current Hematologic Malignancy Reports
5. Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells
   Veronika Kulikova, Konstantin A. Shabalin, Kirill Nerinovski, Alexander Yakimov, Maria Svetlova, Ljudmila Solovjeva, Andrey Kropotov, Mikhail Khodorkovskiy, Marie E. Migaud, Mathias Ziegler et al. · 2019 · Metabolites
6. Autism - A Neurodevelopmental Journey from Genes to Behaviour
   Valsamma Eapen · 2011 · InTech eBooks
7. CD 38 modulates respiratory syncytial virus‐driven proinflammatory processes in human monocyte‐derived dendritic cells
   Ilaria Schiavoni, Carolina Scagnolari, Alberto L. Horenstein, Pasqualina Leone, Alessandra Pierangeli, Fabio Malavasi, Clara Maria Ausiello, Giorgio Fedele · 2017 · Immunology
8. Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab
   Kyeongmin Kim, Mitch A. Phelps · 2023 · Clinical Pharmacokinetics
9. ATRA-Induced Cellular Differentiation and CD38 Expression Inhibits Acquisition of BCR-ABL Mutations for CML Acquired Resistance
   Zhiqiang Wang, Zheng Liu, Xiwei Wu, Su Chu, Jinhui Wang, Hongfeng Yuan, Mendel Roth, Yate‐Ching Yuan, Ravi Bhatia, Wenyong Chen · 2014 · PLoS Genetics
10. Two novel mechanisms for maintenance of stemness in mesenchymal stem cells: SCRG1/BST1 axis and cell–cell adhesion through N-cadherin
    Naoyuki Chosa, Akira Ishisaki · 2017 · Japanese Dental Science Review
11. Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets
    Tiziana Vaisitti, Francesca Arruga, Giulia Guerra, Silvia Deaglio · 2019 · Frontiers in Immunology
12. Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
    Yelei Guo, Kaichao Feng, Chuan Tong, Hejin Jia, Yang Liu, Yao Wang, Dongdong Ti, Qingming Yang, Zhiqiang Wu, Weidong Han · 2020 · Cellular and Molecular Immunology
13. Lymphocyte subsets in human immunodeficiency virus-unexposed Brazilian individuals from birth to adulthood
    Maria Isabel de Moraes‐Pinto, Érika Ono, Elisangela Santos-Valente, Liziane C Almeida, Paula Rosenberg de Andrade, Maria Isabel Saraiva Dinelli, Amélia Miyashiro Nunes dos Santos, Reinaldo Salomão · 2014 · Memórias do Instituto Oswaldo Cruz
14. CD38 Mediates Angiotensin II–Induced Intracellular Ca2+ Release in Rat Pulmonary Arterial Smooth Muscle Cells
    Suengwon Lee, Omkar Paudel, Yongliang Jiang, Xiao-Ru Yang, James S.K. Sham · 2015 · American Journal of Respiratory Cell and Molecular Biology
15. Identifying Glyceraldehyde 3-Phosphate Dehydrogenase as a Cyclic Adenosine Diphosphoribose Binding Protein by Photoaffinity Protein–Ligand Labeling Approach
    Kehui Zhang, Wei Sun, Lihong Huang, Kaiyuan Zhu, Fen Pei, Longchao Zhu, Qian Wang, Yingying Lü, Hongmin Zhang, Hongwei Jin et al. · 2016 · Journal of the American Chemical Society
16. An update on the role of daratumumab in the treatment of multiple myeloma
    Caitlin L. Costello · 2016 · Therapeutic Advances in Hematology
17. A Low Frequency of IL-17-Producing CD8+ T-Cells Is Associated With Persistent Immune Activation in People Living With HIV Despite HAART-Induced Viral Suppression
    Federico Perdomo-Celis, Manuel G. Feria, Natalia A. Taborda, Marı́a Teresa Rugeles · 2018 · Frontiers in Immunology
18. CD38: A Potential Therapeutic Target in Cardiovascular Disease
    Wanyun Zuo, Na Liu, Yunhong Zeng, Yaozhong Liu, Biao Li, Keke Wu, Yunbin Xiao, Qiming Liu · 2020 · Cardiovascular Drugs and Therapy
19. CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
    Dario Roccatello, Roberta Fenoglio, Savino Sciascia, Carla Naretto, Daniela Rossi, Michela Ferro, Antonella Barreca, Fabio Malavasi, Simone Baldovino · 2020 · International Journal of Molecular Sciences
20. The Extracellular NADome Modulates Immune Responses
    Valentina Audrito, Vincenzo Gianluca Messana, Lorenzo Brandimarte, Silvia Deaglio · 2021 · Frontiers in Immunology
21. Novel Approaches Used to Examine and Control Neurogenesis in Parkinson′s Disease
    Alla B. Salmina, Капкаева Марина Рафаилевна, Anna S. Vetchinova, Sergey Nikolaevich Illarioshkin · 2021 · International Journal of Molecular Sciences
22. Targeting CD38 in Neoplasms and Non-Cancer Diseases
    Wojciech Szlasa, Jakub Czarny, Natalia Julia Sauer, Katarzyna Rakoczy, Natalia Szymańska, Jakub Stecko, Maksymilian Kołodziej, Maciej Kaźmierczak, Ewa Barg · 2022 · Cancers
23. Mechanism-Based Small Molecule Probes for Labeling CD38 on Live Cells
    Hong Jiang, Johanna Congleton, Qun Liu, Paolomi Merchant, Fabio Malavasi, Hon Cheung Lee, Quan Hao, Andrew Yen, Hening Lin · 2009 · Journal of the American Chemical Society
24. Expression of the Human NAD(P)-Metabolizing Ectoenzyme CD38 Compromises Systemic Acquired Resistance inArabidopsis
    Xudong Zhang, Zhonglin Mou · 2012 · Molecular Plant-Microbe Interactions
25. The Regulatory Role of NAD in Human and Animal Cells
    Veronika Kulikova, D. V. Gromyko, Andrey A. Nikiforov · 2018 · Biochemistry (Moscow)
26. Immunotherapy in multiple myeloma
    Yamna Jadoon, Mustaqeem Ahmad Siddiqui · 2021 · Cancer Treatment and Research Communications
27. Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
    Haotian Wu, Xiaosu Zhao · 2022 · International Journal of Biological Sciences
28. Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management
    Fiammetta Vanoli, Renato Mantegazza · 2022 · Neurotherapeutics
29. Inhibition of Cardiomyocytes Differentiation of Mouse Embryonic Stem Cells by CD38/cADPR/Ca2+ Signaling Pathway
    Wenjie Wei, Hai‐Ying Sun, Kai Yiu Ting, Lihe Zhang, Hon-Cheung Lee, Gui‐Rong Li, Jianbo Yue · 2012 · Journal of Biological Chemistry
30. Practical approaches and costs for provisioning safe transfusions during anti‐CD38 therapy
    Waseem Q. Anani, Marisela Marchan, Kathleen M. Bensing, Michael Schanen, Cindy Piefer, Jerome L. Gottschall, Gregory Andrew Denomme · 2017 · Transfusion
31. CD38 protein deficiency induces autoimmune characteristics and its activation enhances IL‐10 production by regulatory B cells
    Marilú Domínguez-Pantoja, Gabriela López‐Herrera, Héctor Romero‐Ramírez, Leopoldo Santos‐Argumedo, Adriana Karina Chávez-Rueda, María de los Ángeles Hernández-Cueto, Mónica Flores‐Muñoz, Juan Carlos Rodríguez‐Alba · 2018 · Scandinavian Journal of Immunology
32. Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance
    Danilo De Novellis, Raffaele Fontana, Valentina Giudice, Bianca Serio, Carmine Selleri · 2022 · International Journal of Molecular Sciences
33. Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses
    Arnt‐Ove Hovden, Marie Karlsen, Roland Jonsson, Hans Jørgen Aarstad, Silke Appel · 2011 · BMC Immunology
34. Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis
    Bar Ben Baruch, Eran Blacher, Einav Mantsur, Hila Doron, Hananya Vaknine, Neta Erez, Reuven Stein · 2018 · Oncotarget
35. CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer
    Pin Wu, Lufeng Zhao, Yongyuan Chen, Zhongwei Xin, Mingjie Lin, Zhixing Hao, Xiaoke Chen, Di Chen, Dang Wu, Ying Chai · 2021 · Cancer Immunology Immunotherapy
36. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells
    Rodica Petruta Bunaciu, Holly A. Jensen, Robert J. MacDonald, Dorian H. LaTocha, Jeffrey D. Varner, Andrew Yen · 2015 · PLoS ONE
37. Autophagy maturation associated with CD 38‐mediated regulation of lysosome function in mouse glomerular podocytes
    Jing Xiong, Min Xia, Ming Xu, Yang Zhang, Justine M. Abais, Guangbi Li, Christopher R. Riebling, Joseph K. Ritter, Krishna Murthy Boini, Pin‐Lan Li · 2013 · Journal of Cellular and Molecular Medicine
38. Potent anti‐tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma
    Felix Oden, Stephen F. Marino, Janko Brand, Susanne Scheu, Cathleen Kriegel, Daniel Olal, Anna Takvorian, Jörg Westermann, Buket Yilmaz, Michael Hinz et al. · 2015 · Molecular Oncology
39. All-transretinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-δ
    Akira Uruno, Naoya Noguchi, Ken Matsuda, Koji Nata, Takeo Yoshikawa, Youichiro Chikamatsu, Hiroyuki Kagechika, Hideo Harigae, Sadayoshi Ito, Hiroshi Okamoto et al. · 2011 · Journal of Leukocyte Biology
40. Sex-related differences in human plasma NAD+/NADH levels depend on age
    Luisa Schwarzmann, Rainer Ullrich Pliquett, Andreas Simm, Babett Bartling · 2021 · Bioscience Reports
41. Cell-Intrinsic CD38 Expression Sustains Exhausted CD8 + T Cells by Regulating Their Survival and Metabolism during Chronic Viral Infection
    Julia M. DeRogatis, Emily N. Neubert, Karla M. Viramontes, Monique L. Henriquez, Dequina Nicholas, Roberto Tinoco · 2023 · Journal of Virology
42. Are retinoids potential therapeutic agents in disorders of social cognition including autism?
    Richard P. Ebstein, David Mankuta, Nurit Yirmiya, Fabio Malavasi · 2011 · FEBS Letters
43. BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population
    Meng‐Ling Chen, Chin‐Hsien Lin, Ming‐Jen Lee, Ruey‐Meei Wu · 2013 · Parkinsonism & Related Disorders
44. CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells
    Silvia Deaglio, Tiziana Vaisitti, Antonella Zucchetto, Valter Gattei, Fabio Malavasi · 2010 · Seminars in Cancer Biology
45. Insights into the Mechanism of Bovine CD38/NAD+Glycohydrolase from the X-Ray Structures of Its Michaelis Complex and Covalently-Trapped Intermediates
    Pascal F. Egea, Hélène Muller‐Steffner, Isabelle Kuhn, Céline Cakir‐Kiefer, Norman J. Oppenheimer, Robert Michael Stroud, Esther Kellenberger, Francis J. Schuber · 2012 · PLoS ONE
46. Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation
    Karl Walter Bock · 2020 · Biochemical Pharmacology
47. The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
    Long Gao, Yuan Liu, Xiaohong Du, Sai Ma, Minmin Ge, Haijun Tang, Chenfeng Han, Xin Zhao, Yanbin Liu, Yun Shao et al. · 2021 · Cell Death and Disease
48. Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells
    Alessandro Camponeschi, Kathrin Kläsener, Timothy Sundell, Christina Lundqvist, Paul T. Manna, Negar Ayoubzadeh, Martina Sundqvist, Katrin Thorarinsdottir, Mariele Gatto, Marcella Visentini et al. · 2022 · The Journal of Experimental Medicine
49. The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives
    Daniele Caracciolo, Antonia Mancuso, Nicoletta Polerà, Caterina Froio, Giuseppe D’Aquino, Caterina Riillo, Pierosandro Tagliaferri, Pierfrancesco Tassone · 2023 · Experimental Hematology and Oncology
50. Binding of CD157 Protein to Fibronectin Regulates Cell Adhesion and Spreading
    Simona Morone, Stefania Augeri, Massimiliano Cuccioloni, Matteo Mozzicafreddo, Mauro Angeletti, Nicola Lo Buono, Alice Giacomino, Erika Ortolan, Ada Funaro · 2014 · Journal of Biological Chemistry
51. Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions
    Sonia Scarfı̀ · 2014 · World Journal of Stem Cells
52. Cellular and Mitochondrial NAD Homeostasis in Health and Disease
    Jaylyn Waddell, Rehana Khatoon, Tibor Kristián · 2023 · Cells
53. ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary
    Johanna Congleton, Hong Jiang, Fabio Malavasi, Hening Lin, Andrew Yen · 2010 · Experimental Cell Research
54. An emerging role for NAADP-mediated Ca2+signaling in the pancreatic β-cell
    Abdelilah Arredouani, A. Mark Evans, Jianjie Ma, John Parrington, Michael X. Zhu, Anthony Galione · 2010 · Islets
55. CD38 Deficiency Promotes Inflammatory Response through Activating Sirt1/NF-κB-Mediated Inhibition of TLR2 Expression in Macrophages
    Yisong Qian, Chuqiao Chen, Leliang Ma, Ziwei Wang, Ling-Fang Wang, Li Zuo, Yaqin Yang, Xiang Huang, Meixiu Jiang, Xiaolei Wang et al. · 2018 · Mediators of Inflammation
56. Implications of NAD + boosters in translational medicine
    Baeki E. Kang, Jun‐Yong Choi, Sokrates Stein, Dongryeol Ryu · 2020 · European Journal of Clinical Investigation
57. CD38 as an Immunomodulator in Cancer
    Yanli Li, Rui Yang, Limo Chen, Sufang Wu · 2020 · Future Oncology
58. PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression
    Federica Costa, Valentina Marchica, Paola Storti, Fabio Malavasi, Nicola Giuliani · 2021 · Cancers
59. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
    Ha Gyeong Shin, Ha Rim Yang, Aerin Yoon, Sukmook Lee · 2022 · International Journal of Molecular Sciences
60. Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
    Simona Morone, Nicola Lo Buono, Rossella Parrotta, Alice Giacomino, Giulia Nacci, Alfredo Brusco, Alexey A. Larionov, Paola Ostano, Maurizia Mello Grand, Giovanna Chiorino et al. · 2012 · PLoS ONE
61. Cyclic ADP ribose is a novel regulator of intracellular Ca2+ oscillations in human bone marrow mesenchymal stem cells
    Rong Tao, Hai‐Ying Sun, Chu‐Pak Lau, Hung‐Fat Tse, Hon-Cheung Lee, Gui-Rong Li · 2011 · Journal of Cellular and Molecular Medicine
62. The ΔC splice‐variant of TRPM2 is the hypertonicity‐induced cation channel in HeLa cells, and the ecto‐enzyme CD38 mediates its activation
    Tomohiro Numata, Kaori Sato-Numata, Jens Christmann, Romy Marx, Yasuo Mori, Yasunobu Okada, Frank Wehner · 2012 · The Journal of Physiology
63. Multifunctional Roles of NAD+ and NADH in Astrocytes
    Franziska Wilhelm, Johannes Hirrlinger · 2012 · Neurochemical Research
64. Regulation of CD38 Expression in Human Airway Smooth Muscle Cells
    Joseph Antony Jude, Krishnaswamy Gopalan Tirumurugaan, Bit Na Kang, Reynold A. Panettieri, Timothy Francis Walseth, Mathur Kannan · 2012 · American Journal of Respiratory Cell and Molecular Biology
65. Ectoenzymes in leukocyte migration and their therapeutic potential
    Marko Salmi, Sirpa Jalkanen · 2014 · Seminars in Immunopathology
66. Two Different Methods of Quantification of Oxidized Nicotinamide Adenine Dinucleotide (NAD+) and Reduced Nicotinamide Adenine Dinucleotide (NADH) Intracellular Levels: Enzymatic Coupled Cycling Assay and Ultra-performance Liquid Chromatography (UPLC)-Mass Spectrometry
    Karina S. Kanamori, Guilherme C. de Oliveira, Maria Auxiliadora‐Martins, Renee A. Schoon, Joel M. Reid, Eduardo N. Chini · 2018 · BIO-PROTOCOL
67. IFN-γ and CD38 in Hyperprogressive Cancer Development
    Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, Laura Scalambra, Francesco Gelsomino, Andrea Ardizzoni, Patrizia Nanni, Pier‐Luigi Lollini, Arianna Palladini · 2021 · Cancers
68. T-Cell Immune Imbalance in Rheumatoid Arthritis Is Associated with Alterations in NK Cells and NK-Like T Cells Expressing CD38
    Hongxing Wang, Kehua Fang, Weining Yan, Xiaotian Chang · 2021 · Journal of Innate Immunity
69. An NADH-selective and sensitive fluorescence probe to evaluate living cell hypoxic stress
    Mingzhe Li, Chang Liu, Wenjuan Zhang, Longfei Xu, Miaomiao Yang, Zhaoli Chen, Xinxing Wang, Lingling Pu, Weili Liu, Xianshun Zeng et al. · 2021 · Journal of Materials Chemistry B
70. Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
    Meike Farber, Yiyang Chen, Lucas Arnold, Michael Möllmann, Eva Boog-Whiteside, Yu-An Lin, Hans Christian Reinhardt, Ulrich Dührsen, Maher Hanoun · 2021 · Scientific Reports
71. Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
    Matteo Simonelli, Elena Garralda, Ferry A.L.M. Eskens, Marta Gil-Martín, C.-J. Yen, Radka Lordick Obermannova, Yee Chao, Sara Lonardi, Bohuslav Melichar, V. Moreno et al. · 2022 · ESMO Open
72. Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma
    Sergio A. Giralt, Stephen R.A. Jolles, Tessa C. C. Kerre, Hillard Michael Lazarus, Syed Shahzad Mustafa, Genovefa A. Papanicolaou, Roberto Ria, Donald Cuong Vinh, John R. Wingard · 2023 · Clinical Lymphoma Myeloma & Leukemia
73. CD38 and bone marrow microenvironment
    Antonella Chillemi · 2014 · Frontiers in bioscience
74. CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production
    Qianting Yang, Mingfeng Liao, Wenfei Wang, Mingxia Zhang, Qi Chen, Jiubiao Guo, Bin Peng, Jian Huang, Haiying Liu, Ayano Yahagi et al. · 2019 · mBio
75. CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers
    Ying Jiao, Ming Yi, Linping Xu, Qian Chu, Yongxiang Yan, Suxia Luo, Kongming Wu · 2020 · Expert Opinion on Investigational Drugs
76. NAD+‐metabolizing ecto‐enzymes shape tumor–host interactions: The chronic lymphocytic leukemia model
    Tiziana Vaisitti, Valentina Audrito, Sara Serra, Cinzia Bologna, Davide Brusa, Fabio Malavasi, Silvia Deaglio · 2011 · FEBS Letters
77. The hidden life of NAD+-consuming ectoenzymes in the endocrine system
    Fabio Malavasi, Silvia Deaglio, Gianluca Zaccarello, Alberto L. Horenstein, Antonella Chillemi, Valentina Audrito, Sara Serra, Marina Gandione, Andrea Zitella, Alessandro Tizzani · 2010 · Journal of Molecular Endocrinology
78. B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue
    Diana M. Castañeda, Doris M. Salgado, Carlos Fernando Narváez · 2016 · Virology
79. Daratumumab: A review of current indications and future directions
    Elizabeth Hill, Candis Morrison, Dickran Gano Kazandjian · 2022 · Seminars in Oncology
80. Evolving roles of CD38 metabolism in solid tumour microenvironment
    Long Gao, Xiaohong Du, Jiabin Li, Frank Xiao-Feng Qin · 2022 · British Journal of Cancer
81. Fine mapping of a distal chromosome 4 QTL affecting growth and muscle mass in a chicken advanced intercross line
    Shijie Lyu, Danny Arends, Mostafa K. Nassar, Gudrun A. Brockmann · 2017 · Animal Genetics
82. Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
    Xun Ma, Sandy Wai Kuan Wong, Ping Zhou, Chakra P. Chaulagain, Parul D Doshi, Andreas K. Klein, Kellie Sprague, Adin Kugelmass, Denis Toskic, Melissa T. Warner et al. · 2018 · Experimental Hematology and Oncology
83. NAD metabolism in aging and cancer
    John W. R. Kincaid, Nathan A. Berger · 2020 · Experimental Biology and Medicine
84. Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer
    Renata Novak Kujundžić, Marin Prpić, Nikola Đaković, Nina Dabelić, Marko Tomljanović, Anamarija Mojzeš, Ana Fröbe, Koraljka Gall‐Tros̆elj · 2021 · International Journal of Molecular Sciences
85. Association Study between the CD157/BST1 Gene and Autism Spectrum Disorders in a Japanese Population
    Shigeru Yokoyama, Naila Al Mahmuda, Toshio Munesue, Kenshi Hayashi, Kunimasa Yagi, Masakazu Yamagishi, Haruhiro Higashida · 2015 · Brain Sciences
86. Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
    Dan Su, Gao Wu, Ran Xiong, Xiangxiang Sun, Meiqing Xu, Yide Mei, Xianning Wu · 2021 · Frontiers in Oncology
87. On the road to eliminating long‐lived plasma cells—“are we there yet?”
    Caroline Markmann, Vijay G. Bhoj · 2021 · Immunological Reviews
88. Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
    Piero Giuseppe Meliante, Christian Barbato, Federica Zoccali, Massimo Ralli, Antonio Greco, Marco DE VINCENTIIS, Andrea Colizza, Carla Petrella, Giampiero Ferraguti, Antonio Minni et al. · 2022 · International Journal of Molecular Sciences
89. Monoclonal Antibodies as Therapeutics in Human Malignancies
    Manjari Pandey, Daruka Mahadevan · 2014 · Future Oncology
90. Physiological roles of NAADP-mediated Ca2+ signaling
    Anthony Galione, John Parrington, Tim M. Funnell · 2011 · Science China Life Sciences
91. Regulation of the renal microcirculation by ryanodine receptors and calcium-induced calcium release
    William J. Arendshorst, Tiffany L. Thai · 2008 · Current Opinion in Nephrology & Hypertension
92. Leukocyte Membrane Enzymes Play the Cell Adhesion Game
    Georgina I. López-Cortés, Laura Díaz-Alvarez, Enrique Ortega · 2021 · Frontiers in Immunology
93. Ectoenzymes controlling leukocyte traffic
    Marko Salmi, Sirpa Jalkanen · 2012 · European Journal of Immunology
94. Immunotherapy
    Salma Afifi, Angela Michael, Alexander M. Lesokhin · 2016 · Annals of Pharmacotherapy
95. Regulation of Cancer and Cancer-Related Genes via NAD +
    Tanveer Sharif, Emma Martell, Cathleen Dai, Mohammad Saleh Ghassemi-Rad, Barry E. Kennedy, Patrick W.K. Lee, Shashi Ashok Gujar · 2018 · Antioxidants and Redox Signaling
96. Aryl hydrocarbon receptor (AHR) functions in NAD+ metabolism, myelopoiesis and obesity
    Karl Walter Bock · 2019 · Biochemical Pharmacology
97. CD38 deficiency up-regulated IL-1β and MCP-1 through TLR4/ERK/NF-κB pathway in sepsis pulmonary injury
    Yuna Du, Huiqing Zhang, Yujie Guo, Kuangyu Song, Lifeng Zeng, Yiguo Chen, Zhengyu Xie, Rong Li · 2021 · Microbes and Infection
98. B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses
    Dorit Verhoeven, Lucas Grinwis, Casper Marsman, Machiel H. Jansen, Ester M. M. van Leeuwen, Taco Willem Kuijpers · 2023 · Life Science Alliance
99. Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment
    Kyra Laubach, Tolga Turan, Rebecca S. Mathew, Julie L. Wilsbacher, John Engelhardt, Josue A. Samayoa · 2023 · Cancer Drug Resistance
100. CD38 Monoclonal Antibody Therapies for Multiple Myeloma
     Sandy Wai Kuan Wong, Raymond L. Comenzo · 2015 · Clinical Lymphoma Myeloma & Leukemia